Sep 12, 2022
This is a translation of the Swedish press release published 2022-09-12 Neola Medical AB (publ) will participate at ABG Sundal Colliers Investor Day in Stockholm the 13th of September and present the company. At 15.00 (3 pm) CEO Hanna Sjöström will present the...
Sep 8, 2022
This is a translation of the Swedish press release 2022-09-08 Shareholders in Neola Medical AB, org.nr 559069–9012 (”the Company”), are hereby given notice of the extraordinary general meeting the 27th of September 2022. The board of directors has decided in...
Sep 8, 2022
This is a translation of the Swedish press release published 2022-09-08, 08:00 CET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND,...
Sep 6, 2022
This weekend our Clinical Manager, Tetiana Kovtiukh, visited the UENPS (Unition of European Neonatal & Perinatal Societies) congress in Krakow, Poland. UENPS mission is to develop the European neonatal and perinatal care and the overall goal is to develop the...
Sep 1, 2022
“It has been just over two years since Nasdaq’s listing bell rang at Medicon Village and Neola Medical entered the stock market. A lot has happened since then and the company’s focus is now all on preparing for market launch in the US. BioStock contacted Neola...
Sep 1, 2022
This is a translation of the Swedish press release published 2022-09-01 Neola Medical AB (publ) announces that PhD MD Tetiana Kovtiukh has been recruited as Clinical Manager, starting her full-time position in September 2022. Tetiana will ensure clinical compatibility...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
